McCune-Albright Syndrome: Clinical Trials
Featured NICHD Clinical Trials on MAS
Testolactone for the Treatment of Girls with LHRH Resistant Precocious Puberty. Researchers conducted this study to determine whether the drug testolactone could slow or stop precocious puberty by preventing the last step of estrogen production in the ovaries.
ClinicalTrials.gov Search Results
Information on current NIH-sponsored clinical trials on McCune-Albright syndrome is available at the link below or by calling 800-411-1222.
Last Updated Date: 11/30/2012
Last Reviewed Date: 11/30/2012